News Archive

A new type of anti-clotting drug caused fewer bleeding incidents among patients with atrial fibrillation than the commonly prescribed apixaban, according to results from a head-to-head comparison of the two.

Heart failure patients taking the investigational drug omecamtiv mecarbil, which has been previously shown to improve long-term outcomes, see little impact on their ability to exercise compared to a placebo, according to a study supported by the Duke Clinical Research Institute.

Less than half of the patients with first-detected atrial fibrillation (AFib) receive rhythm control at admission, according to data analysis from the nationwide Get With The Guidelines®-Atrial Fib

School districts that required masking saw lower rates of COVID-19 transmission within schools last fall compared to those with optional masking policies, according to a study by the ABC Science Collaborative.

A pragmatic, open-label, randomized trial of 1,201 patients found as-needed use of inhaled glucocorticoids plus existing therapy improved asthma outcomes in a broad population of Black and Latinx patients with poorly controlled asthma.

Healthcare workers who have children under age 5 are twice as likely as other parents to plan to vaccinate their children against COVID-19, according to a new poll conducted by the HERO Registry coordinated by the Duke Clinical Research Institute.

Web and phone-based enrollment allows people to help test potential COVID-19 treatments without leaving home.

The pragmatic clinical trial was the first demonstration project of PCORnet®, the Patient-Centered Clinical Research Network, which is an integrated partnership of clinical research networks funded by the Patient-Centered Outcomes Research Institute (PCORI).

The pragmatic clinical trial was the first demonstration project of PCORnet®, the Patient-Centered Clinical Research Network, which is an integrated partnership of clinical research networks funded

The below is a republication of a story that originally appeared on the